4 October, 7.30-8.45 CET, Bad Hofgastein
This breakfast session will offer an open debate on the role of IP in EU healthcare innovation, focused on the appropriate role and balance for both public funding and private investments, supported by new research on EU biotech success factors produced by Vital Transformation.
25 Oct 2017 8:00 AM – 26 Oct 2017 3:30 PM Radisson Blu Steinentorstrasse 25 4001 Basel Switzerland
February 13th, 2017
This webinar will discuss the mounting challenges to Europe's ATMP sector, and offer tangible suggestions as to what needs to be done to ensure the EU maintains its ability to develop needed new therapies and bring them to patients
March 28th, 2017
DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.
24th November 2016
IMI 1 GetReal closing meeting: ‘Delivering tools for real-world evidence development’
Supported by:
October 6, 2016
WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.
June 29, 2016, Philadelphia Europe and the US are experimenting with ways to develop therapies based on their actual ‘real world’ performance. This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.
